Today: 30 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm shares fell 2.3% to $1,271.89 Wednesday after Baird downgraded the stock and cut its price target to $1,400. The company reported a 14% rise in net sales to $2.285 billion for the fiscal first quarter, but net income dropped nearly 10% to $445 million due to higher interest expenses. TransDigm raised its 2026 profit forecast but kept the midpoint below analyst expectations.
4 February 2026
·
Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific stock price skids as key heart-rhythm sales miss jolts BSX

Boston Scientific shares fell 15% to $77.83 after quarterly electrophysiology sales missed Wall Street estimates, with Q4 revenue in that segment at $890 million versus a $933 million consensus. Analysts flagged fresh doubts about growth in electrophysiology and Watchman devices. The stock’s drop marked its sharpest one-day decline in over 25 years. Investors await Watchman “CHAMPION” trial data at the ACC.26 meeting in March.
4 February 2026
·
Eaton (ETN) stock slips after cautious 2026 outlook — here’s what investors are watching

Eaton (ETN) stock slips after cautious 2026 outlook — here’s what investors are watching

Eaton shares fell 0.9% to $359.17 Wednesday after the company’s 2026 profit forecast missed Wall Street estimates. Data-center orders in Electrical Americas surged 200% in Q4, but first-quarter margin guidance came in below expectations. Management confirmed plans to spin off the mobility business. Fourth-quarter adjusted EPS reached a record $3.33 on $7.1 billion in sales.
4 February 2026
··
SoFi stock tumbles in regular session as post-upgrade bounce fades — what to watch next

SoFi stock tumbles in regular session as post-upgrade bounce fades — what to watch next

SoFi Technologies shares fell 6.4% to $20.37 Wednesday afternoon, erasing earlier gains after a recent J.P. Morgan upgrade. The drop followed a broader selloff in tech stocks and came days after SoFi posted a strong fourth-quarter profit. Chief Risk Officer Arun Pinto entered a prepaid variable forward contract tied to 71,500 shares, netting about $1.2 million upfront. Investors await next week’s delayed U.S. jobs and inflation reports.
4 February 2026
·
Synopsys stock slips again after Tuesday’s rout as AI disruption fears hit software

Synopsys stock slips again after Tuesday’s rout as AI disruption fears hit software

Synopsys shares fell 1.2% to $414.07 Wednesday afternoon, extending losses after an 8.5% drop Tuesday during a broad software sector selloff. Trading volume Tuesday more than doubled its 50-day average, with the stock now 36% below its July peak. Traders remain defensive, with options activity skewed toward downside bets. Synopsys reports Q1 earnings after markets close on Feb. 25.
4 February 2026
··
Johnson & Johnson stock price rises as RBC hikes target; JNJ data catalysts line up next

Johnson & Johnson stock price rises as RBC hikes target; JNJ data catalysts line up next

Johnson & Johnson shares rose 1% to $235.50 Wednesday, bucking a broader market decline. RBC raised its price target to $255, citing strong financials despite ongoing talc litigation. New data showed ERLEADA cut prostate cancer death risk by 51% versus darolutamide. Investors await updates at the AF Symposium on Feb. 6 and a TD Cowen event on March 3.
4 February 2026
···
Accenture stock price today: ACN steadies after rout as AI disruption trade bites

Accenture stock price today: ACN steadies after rout as AI disruption trade bites

Accenture shares rose 0.2% to $241.67 Wednesday after plunging 9.6% the previous day amid a broad tech selloff tied to AI disruption fears and a weak Gartner outlook. CEO Julie Sweet sold 10,696 shares at $262.22 each, according to a Form 4 filing. Investors are watching Accenture’s March 19 results for signs of stability in bookings and client demand.
4 February 2026
···
AMD stock price slides nearly 17% as AI-chip outlook disappoints; Nvidia and Super Micro in focus

AMD stock price slides nearly 17% as AI-chip outlook disappoints; Nvidia and Super Micro in focus

AMD shares fell nearly 17% after forecasting a sequential revenue decline for the first quarter, despite posting record fourth-quarter sales. Super Micro Computer jumped almost 9% after raising its full-year outlook on strong AI server demand. Nvidia slipped about 4%. Traders are watching Nvidia’s Feb. 25 earnings and a delayed U.S. data release for further direction.
4 February 2026
····
Gold price today slips near $4,900 as firmer dollar prompts profit-taking; jobs data in focus

Gold price today slips near $4,900 as firmer dollar prompts profit-taking; jobs data in focus

Spot gold fell 0.6% to $4,907.69 an ounce by midday Wednesday, reversing earlier gains as the dollar strengthened. ADP reported U.S. private payrolls rose by 22,000 in January, missing forecasts. The official jobs report was postponed to Feb. 11 after a government shutdown. Analysts raised 2026 gold price targets, citing central-bank buying and geopolitical risks.
4 February 2026
·
XRP price drops toward $1.50 as Ripple adds Hyperliquid and U.S. policy churn weighs on crypto

XRP price drops toward $1.50 as Ripple adds Hyperliquid and U.S. policy churn weighs on crypto

XRP fell 1.7% to $1.51 in 24 hours, with $4.4 billion in trading volume, as traders watch Federal Reserve leadership uncertainty and stalled stablecoin legislation. Ripple announced its Prime platform now supports Hyperliquid for on-chain derivatives. XRP is down 21% on Coinbase in a week. The SEC fined Ripple $125 million last August and barred XRP institutional sales.
4 February 2026
··
1 … 144 145 146 147 148 … 726

Stock Market Today

  • Novo Nordisk Launches DKK 15 Billion Share Buyback Program
    March 30, 2026, 8:14 AM EDT. Novo Nordisk A/S began a share repurchase programme on 4 February 2026, aiming to buy back B shares worth up to DKK 15 billion over 12 months. Between 4 February and 27 March, the healthcare company repurchased 9.16 million B shares at an average price of DKK 261.91, totaling approximately DKK 2.4 billion. The shares bought are treasury shares representing 0.6% of the company's share capital. Novo Nordisk, headquartered in Denmark, is a global leader in healthcare, primarily focused on diabetes care, employing roughly 68,800 people worldwide. Its B shares trade on Nasdaq Copenhagen and its American Depository Receipts (ADRs) on the New York Stock Exchange.
Go toTop